{"schema_version":"secwatch.filing_event.v1","accession":"0001035267-23-000087","form_type":"8-K","ticker":"ISRG","cik":"0001035267","company_name":"INTUITIVE SURGICAL INC","filed_at":"2023-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.699493+00:00","generated_at":"2026-06-17T00:23:13.142380+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Intuitive Surgical Q1 revenue $1.70B (+14% YoY), da Vinci procedures +26%, non-GAAP EPS $1.23","bullets":["Revenue $1.70B, up 14% YoY; constant currency growth of 17%.","GAAP diluted EPS $1.00 (flat); non-GAAP diluted EPS $1.23 vs $1.13.","da Vinci procedure volume grew ~26% YoY; placed 312 systems; installed base 7,779 (+12%).","Instruments & accessories revenue $986M (+22%); systems revenue $427M (flat).","European certification for Ion endoluminal system obtained; initial focus on UK market."],"urls":{"canonical":"https://secwatch.observer/filing/0001035267-23-000087","json":"https://secwatch.observer/filing/0001035267-23-000087.json","markdown":"https://secwatch.observer/filing/0001035267-23-000087.md","text":"https://secwatch.observer/filing/0001035267-23-000087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035267/000103526723000087/0001035267-23-000087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035267/000103526723000087/isrg-20230418.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T00:23:13.142380+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}